Following the announcement that Sanofi’s global head of R&D John Reed is leaving the French drugmaker, his destination has been revealed as the US healthcare gi 14 February 2023
French drugmaker Sanofi is searching for a new global head of R&D after the role’s current incumbent John Reed announced he was off to pursue an undisclosed opp 13 February 2023
More gloomy news from Finch Therapeutics, as the microbiome company announced it would scrap the Phase III PRISM4 trial of its recurrent C. difficile infection 25 January 2023
A new chief executive is to take over from Jeff Hatfield at Vividion Therapeutics, Bayer’s wholly-owned subsidiary that is using discovery technologies to unloc 24 January 2023
Massachusetts, USA-based psychoactive medicine specialist Sensorium Therapeutics has appointed Jeffrey Brown as chief scientific officer. 19 January 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.